AD patients show up to a 67% decrease in the levels of AChE, while BChE levels rise to 120% of normal level.5 This indicates that BChE could compensate for deficit in AChE by hydrolyzing ACh. The gene discussed is BCHE; the disease is Alzheimer disease.